---
title: "bioAffinity Technologies reports accelerated CyPath Lung sales, Philips partnership to boost veteran screening"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291336898.md"
description: "bioAffinity Technologies reported a nearly 300% surge in April CyPath Lung unit sales and a 69% increase in ordering physician offices. The company announced a partnership with Philips to enhance lung cancer screening for U.S. veterans using mobile CT and CyPath Lung. Additionally, pipeline updates include a pilot study at Brooke Army Medical Center for asthma/COPD diagnostics and preclinical data on siRNA treatments for squamous skin cancer."
datetime: "2026-06-30T21:23:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291336898.md)
  - [en](https://longbridge.com/en/news/291336898.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291336898.md)
generator: "portal-rs"
---

# bioAffinity Technologies reports accelerated CyPath Lung sales, Philips partnership to boost veteran screening

**bioAffinity Technologies reported sharply higher CyPath® Lung unit sales and a partnership with Philips to enhance lung cancer screening for U.S. veterans.**

**Key Highlights:**

-   April CyPath® Lung unit sales rose nearly 300% versus April 2025, signaling strong market adoption.
-   Ordering physician offices and clinics increased 69% from Q1 2025 to Q1 2026, expanding clinical reach.
-   Partnership with Philips and 4DMedical targets enhanced lung screening for U.S. veterans using mobile CT and CyPath® Lung.
-   Pipeline work includes pilot study at Brooke Army Medical Center on companion diagnostics for asthma and COPD using flow cytometry + AI.
-   Preclinical data support topical siRNA approaches that selectively target squamous skin cancer cells, suggesting potential skin cancer treatments.

Original SEC Filing: bioAffinity Technologies, Inc. \[ BIAF \] - 8-K - Jun. 30, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BIAFW.US](https://longbridge.com/en/quote/BIAFW.US.md)
- [BIAF.US](https://longbridge.com/en/quote/BIAF.US.md)
- [PHG.US](https://longbridge.com/en/quote/PHG.US.md)
- [4DX.AU](https://longbridge.com/en/quote/4DX.AU.md)
- [RYLPF.US](https://longbridge.com/en/quote/RYLPF.US.md)

## Related News & Research

- [Philips wins $3 million U.S. patent verdict against China's Quectel](https://longbridge.com/en/news/297223588.md)
- [bioAffinity reports positive preclinical data for siRNA therapy targeting squamous, basal skin cancer cells](https://longbridge.com/en/news/290432024.md)
- [Lotus Lake portfolio company Immupeutics wins China IND clearance for IPM514 mRNA vaccine in lung squamous cancer](https://longbridge.com/en/news/296847935.md)
- [AI turns up a promising finding in cancer data that researchers hadn’t noticed for years](https://longbridge.com/en/news/297215988.md)
- [Sun Summit Announces Closing of $4 Million Non-Brokered Private Placement | SMREF Stock News](https://longbridge.com/en/news/297091774.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**